NXTC NextCure, Inc. Net earnings per share growth this year

NextCure, Inc. (NXTC) develops innovative methods for combating solid tumors, focusing on government reimbursements and insurance. The annual EPS range on GURU.Markets captures profit dynamics, where 68.30 determines the current status of the parameter. Robotic drug synthesis stations enhance efficiency, while the delegation of clinical trials to an external network of specialized laboratories minimizes operational risks.

NextCure (NXTC): Net earnings per share growth this year from 07/04/2022 to 11/12/2026

Analytical breakdowns and data insights for company NextCure, Inc. (NXTC)

- current quotes and average value forecast:

Market Chart NextCure Inc|NXTC - Price Target Chart

- market capitalization data:

Market Valuation NextCure Corporation|NXTC - Total Company Value

- company book value details:

Accounting Value per Share NextCure|NXTC - Company Net Assets|Market Capitalization to Book Value Ratio nextcure.com|NXTC - Aggregate Company Assets

- debt and liquidity details:

- net income and valuation ratios data:

NXTC - Net Profit|Expected Net Profit NextCure, Inc.|NXTC - Price to Earnings Ratio|Future Price to Earnings Multiple NextCure Corporation|NXTC - PEG Multiple|EV/EBITDA Multiple NextCure Corporation|NXTC - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months NextCure|NXTC - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months nextcure.com|NXTC - Earnings per share growth in current year|Projected earnings per share growth rate for next year NextCure, Inc.

Summary company analysis:NXTC (NextCure Inc)

NextCure, Inc. (NXTC) relies on its strong reputation in immuno-oncology and expectations surrounding clinical trials. Earnings per share (EPS) dynamics directly reflect the effectiveness of these developments and R&D expenditures. This metric calculates the percentage deviation of the current EPS from the value of the same period last year. It measures the growth rate of net income available to shareholders. By analyzing the annual EPS growth rate, an investor can distinguish short-term volatility from the fundamental trend.

Key competitors